FDA Approves Targeted Radiotherapy for Neuroendocrine Tumors

The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients with neuroendocrine tumors. The new therapeutic—lutetium (Lu) 177 dotatate (Lutathera)—is a targeted form of systemic radiotherapy.

Read More

Women in Science: AACR Leaders Share Their Stories

In honor of International Day of Women and Girls in Science, a United Nations initiative aimed at narrowing a global gender gap in the scientific work force, several AACR leaders shared how they initially became interested in science, how they built rewarding careers in cancer research, and how they might advise a girl or young woman considering a career in science.

Read More

World Cancer Day: Get the Facts

The American Association for Cancer Research (AACR) is proud to support World Cancer Day, a yearly initiative of the Union for International Cancer Control (UICC). Each February 4, World Cancer Day serves as a rallying cry to raise awareness of the global battle against cancer and of the need for government leaders to make cancer research, prevention, and treatment a national priority.

Read More

Disrupting a Link Between Obesity and Cancer

The obesity epidemic shows no signs of abating. The World Health Organization estimates that the proportion of the world’s population who are obese nearly tripled between 1975 and 2016, with the proportion of adults age 18 or older who are obese reaching 13 percent in 2016. The prevalence of obesity is even higher in the United States.

Read More

How is Obesity Linked to Cancer?

Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated with increased cancer incidence and mortality. To address the link between obesity and cancer, the American Association of Cancer Research is hosting a Special Conference, Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, this week in Austin, Texas.

Read More

Can Molecular Analysis be Tapped to Tackle Brain Cancer?

Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still, understanding the molecular changes that drive brain cancer remains “potentially transformative,” says Paul Mischel, a cancer biologist and neuropathologist at the Ludwig Institute for Cancer Research in San Diego.

Read More

Fostering New Advances in Lung Cancer Research

A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research will convene in San Diego for an international conference organized by the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC). The focus of the conference is “Lung Cancer Translational Science from the Bench to the Clinic.”

Read More

Experts Forecast Cancer Research and Treatment Advances in 2018

This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in the research and treatment of cancer, We asked experts in the fields of immunotherapy, precision medicine, and prevention and disparities research where the cancer research community is headed next and what major accomplishments we might expect in 2018 to take us closer to conquering cancer.

Read More

Reflections on a Year of Progress in Cancer Research

As 2017 draws to a close, I’ve been reflecting on another year in cancer research. As Chief Executive Officer of the American Association for Cancer Research, I am privileged to witness some of the most exciting discoveries that bring us closer to preventing and curing the complex set of diseases we call cancer.

Read More